Unilever sold Zwitsal in 2026 to keep pruning its portfolio around 30 global Power Brands

On 17 September 2026 Unilever announced the sale of Zwitsal, a personal and baby care brand concentrated in the Netherlands and Belgium, to Dutch manufacturer Royal Sanders for an undisclosed sum. The exit carried no drama: Zwitsal is simply regional, and management's operating mandate is to streamline the group around global Power Brands with international scale.

The divestment is one instance of a broader pruning effort. Thirty Power Brands already account for 78% of group turnover and grew 6.0% in H1 2026, ahead of the group's 4.8% underlying sales growth on €25.6 billion of turnover, with underlying operating margin up 10 basis points to 20.3%. Unilever also completed its €800 million productivity program ahead of schedule and plans to demerge its Foods unit.

The strategy has trade-offs the market is watching. Shedding local mainstays concentrates the group in premium segments such as Prestige Beauty — Dermalogica, Paula's Choice — where any growth lag would erode pricing power and demand higher promotional spend. Management nonetheless upgraded its full-year 2026 outlook, projecting underlying sales growth within the 4-6% multi-year range.

H1 2026: 4.8% sales growth, 4.2% volume growth, 20.3% margin on €25.6B turnover; the €800M productivity program finished early.

Zwitsal's presence was concentrated in the Netherlands and Belgium, outside Unilever's core growth roadmap.

Small regional brands split marketing, R&D and operational resources that the 30 Power Brands convert into faster growth.

The €800 million productivity program finished ahead of schedule, freeing capacity to keep reallocating toward scalable categories.

Pruning small regional brands is how a focused portfolio stays focused: each divestment frees marketing, R&D and capital for the few brands big enough to matter.

The sale price was undisclosed and the brand moved to Royal Sanders. Management upgraded its full-year 2026 outlook, projecting underlying sales growth within its 4-6% multi-year guidance range alongside modest margin expansion over 2025's 20.0%. The Foods demerger remains planned. Analysts flag the flip side: with local mainstays trimmed, group volume growth leans harder on premium segments such as Prestige Beauty and Health & Wellbeing, so sub-par performance at Dermalogica or Paula's Choice would demand elevated promotional spend to defend share.